ProQR Therapeutics N.V.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
17.45 |
24.83 |
16.84 |
26.21 |
78.80 |
142.46 |
| Przychód Δ r/r |
0.00% |
42.31% |
-32.19% |
55.64% |
200.63% |
80.79% |
| Przychód (min) |
12.80 |
14.05 |
7.35 |
11.43 |
34.37 |
62.15 |
| Przychód (max) |
24.80 |
40.69 |
30.48 |
47.45 |
142.64 |
257.88 |
| EBITDA (średnia) |
-10.47 |
-14.90 |
-10.10 |
-15.73 |
-47.28 |
-85.48 |
| EBIT (średnia) |
-10.47 |
-14.90 |
-10.10 |
-15.73 |
-47.28 |
-85.48 |
| EBIT % |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
| Zysk netto (średni) |
-30.18 |
-33.40 |
-46.78 |
-46.43 |
-19.76 |
13.55 |
| Zysk netto % |
-172.96% |
-134.51% |
-277.81% |
-177.15% |
-25.08% |
9.51% |
| EPS (średnia) |
-0.33 |
-0.41 |
-0.53 |
-0.52 |
-0.24 |
0.17 |
| Liczba analityków (Przychody) |
6 |
5 |
7 |
4 |
2 |
3 |
| Liczba analityków (EPS) |
4 |
3 |
4 |
4 |
3 |
2 |
| symbol |
PRQR |
PRQR |
PRQR |
PRQR |
PRQR |
PRQR |